Multiplicom launches a DNA-test that identifies genetic risk for Familial Hypercholesterolemia
Niel - Belgium, March 12th, 2015 – Multiplicom N.V. announces the release of a DNA-test identifying the genetic risk for Familial Hypercholesterolemia, a common cause of premature coronary heart disease. On average one in 500 persons is affected worldwide. Early identification can save lives in high-risk families and rapidly excludes non-affected family members from costly clinical surveillance programs.
Multiplicom offers clinical labs early access to its innovative non-invasive prenatal test
Niel - Belgium, February 10th, 2015 – Multiplicom N.V. today announces that it is enrolling molecular diagnostic laboratories in an Early Access Program (EAP) to complete the development of its innovative non-invasive prenatal test (NIPT) branded “Clarigo”. Clarigo identifies fetal aneuploidy – abnormalities of the chromosome number - through the analysis of free circulating DNA isolated from the mother’s blood.
Bridging the Gap - ASOC and MGSA Meeting
Auckland I New Zealand
Molecular Dx Europe
Portugal I Lisbon
Technical Workshop: Integrated germline MASTR solutions for clinical diagnostics and new NIAT test
Austria I Graz
5th Slovene Medical Genetics Symposium
Slovenia I Ljubljana